Results 211 to 220 of about 68,419 (288)

Pure Red Cell Aplasia as an Isolated Paraneoplastic Manifestation of Thymoma: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Thymomas are epithelial tumors of the anterior mediastinum and are frequently associated with paraneoplastic autoimmune disorders. Pure red cell aplasia (PRCA) is a rare but clinically significant complication, caused by immune‐mediated suppression of erythropoiesis.
Heba Amer, Modar Alajlani, Mhd Rashad Jamle, Hareth Almanfe, Mohammad Shbat, Mohammad Abd Alrahman Saif, Anas Abdulrazzak, Ahmed Nabhan, Bassam Darwish   +8 more
wiley   +1 more source

Late‐Onset Diagnosis of Tuberous Sclerosis Complex Revealed by Renal Angiomyolipoma: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder characterized by multisystem hamartomas caused by pathogenic variants in TSC1 or TSC2. It is typically diagnosed in childhood, most often because of neurological or dermatological manifestations.
A. Fekih, W. Heni, C. Messaoudi, Y. Selmi, D. Touati, Z. Elloumi, J. Labidi   +6 more
wiley   +1 more source

Spinal Cord Involvement in Neurosarcoidosis: A Case of Longitudinally Extensive Transverse Myelitis at Disease Onset

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Acute‐onset neurological deficits in otherwise healthy individuals warrant a broad differential diagnosis. Neurosarcoidosis presenting as longitudinally extensive transverse myelitis is rare, mimicking demyelinating, infectious, or neoplastic disorders. Early recognition, histopathological confirmation, and timely immunosuppressive therapy are
Areeb Tiwana, Vicky Elias Nahra, Muhammad Adeel Hassan   +2 more
wiley   +1 more source

Extralobar Pulmonary Sequestration Diagnosed as a Mediastinal Tumor and Resected by Robotic Surgery. [PDF]

Ann Thorac Surg Short Rep
Ueno H, Watanabe H, Okado S, Kadomatsu Y, Kato T, Nakamura S, Mizuno T, Chen-Yoshikawa TF.   +7 more
europepmc   +1 more source

MITF Gain‐of‐Function Mutation in Metastatic Prostate Cancer: A Rare Finding With Potential Therapeutic Significance

Cancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Prostate cancer is the most common non‐cutaneous malignancy in men and remains a leading cause of cancer‐related mortality, particularly in aggressive variants. These tumors are usually associated with alterations in TP53, RB1, and PTEN.
Paul J. Pecorin, Nyembezi Dhliwayo, Matthew Demetrious, Ludimila Cavalcante, Veronica Rodriguez‐Bravo, Josep Domingo‐Domenech, Thomas Westbrook   +6 more
wiley   +1 more source

Type II pleuropulmonary blastoma in a fetus: case report of a rare mesenchymal mediastinal tumor and literature review. [PDF]

Arch Clin Cases
Moldovan VT, Sajin M, Habago SD, Ali L.
europepmc   +1 more source

Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus‐Associated Disorders

Cancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Kaposi sarcoma herpes virus (KSHV) is associated with multiple clinical manifestations, including primary effusion lymphoma, an aggressive CD38+ B cell lymphoma with a plasmablastic phenotype. Case This case describes an antiretroviral therapy‐adherent person with HIV who presented with concurrent KSHV‐related disorders of Kaposi ...
Kandice Roberts, Paula Valiño Ramos, Saurabh Jindal, Vikas Prasad, Yi Shan Lee, Mariam Khanfar, Obi L. Griffith, Malachi Griffith, Jeanne Jiang, Ethel Cesarman, Daniel Rauch, Paul Simonson, Thomas Odeny, Lee Ratner   +13 more
wiley   +1 more source

Clinical efficiency of three-port inflatable robot-assisted thoracoscopic surgery in mediastinal tumor resection. [PDF]

World J Surg Oncol
Peng H, He Y, Sheng S, Maitiyasen M, Li J, Liu Y, Chen J, Hou X, Song H, Yi J.   +9 more
europepmc   +1 more source

A Phase 1 Study to Assess the Relative Bioavailability of Brigatinib Administered as an Oral Solution Versus an Immediate‐Release Tablet in Healthy Adults

Clinical Pharmacology in Drug Development, Volume 15, Issue 6, June 2026.
Abstract Brigatinib is an ALK tyrosine kinase inhibitor approved for the treatment of adults with ALK+ non‐small cell lung cancer. The commercial formulation of brigatinib is an immediate‐release (IR) tablet; however, an oral solution was developed for use in pediatric studies for patients unable to swallow solid oral dosage forms. This randomized, two‐
Michael J. Hanley, Ronald Gounden, Bradley Hupf, Saurabh Sarkar, Robert J. Fram, Neeraj Gupta   +5 more
wiley   +1 more source

Robot-assisted thoracoscopic resection of a posterior mediastinal tumor with immunoglobulin G4-related disease: a case report. [PDF]

J Cardiothorac Surg
Takeuchi T, Takizawa H, Bando Y, Hosokawa A, Sumitomo H, Miyamoto N, Sakamoto S, Morishita A, Kawakita N, Toba H.   +9 more
europepmc   +1 more source